Panagora Asset Management’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,036
Closed -$91.3K 1210
2025
Q1
$91.3K Sell
14,036
-183
-1% -$2.88K ﹤0.01% 1081
2024
Q4
$262K Sell
14,219
-10,262
-42% -$313K ﹤0.01% 998
2024
Q3
$847K Sell
24,481
-66,269
-73% -$2.6M ﹤0.01% 774
2024
Q2
$2.66M Buy
90,750
+12,230
+16% +$484K 0.01% 450
2024
Q1
$4.44M Buy
78,520
+33,351
+74% +$1.47M 0.02% 365
2023
Q4
$1.94M Buy
45,169
+8,254
+22% +$262K 0.01% 573
2023
Q3
$1.28M Buy
36,915
+2,816
+8% +$123K 0.01% 699
2023
Q2
$1.59M Sell
34,099
-9,099
-21% -$453K 0.01% 621
2023
Q1
$2M Buy
43,198
+11,900
+38% +$755K 0.01% 574
2022
Q4
$2.53M Buy
31,298
+5,864
+23% +$408K 0.02% 558
2022
Q3
$1.41M Buy
25,434
+8,595
+51% +$509K 0.01% 724
2022
Q2
$877K Buy
16,839
+4,933
+41% +$276K 0.01% 931
2022
Q1
$979K Sell
11,906
-2,629
-18% -$250K 0.01% 949
2021
Q4
$2.16M Sell
14,535
-878
-6% -$157K 0.01% 621
2021
Q3
$2.91M Buy
15,413
+261
+2% +$49.6K 0.02% 569
2021
Q2
$2.82M Buy
15,152
+8,425
+125% +$1.65M 0.02% 606
2021
Q1
$1.53M Buy
6,727
+182
+3% +$43.2K 0.01% 848
2020
Q4
$1.42M Buy
6,545
+2,461
+60% +$407K 0.01% 824
2020
Q3
$410K Sell
4,084
-79
-2% -$7.46K ﹤0.01% 1250
2020
Q2
$323K Buy
4,163
+1,935
+87% +$186K ﹤0.01% 1359
2020
Q1
$227K Buy
2,228
+2,158
+3,083% +$227K ﹤0.01% 1424
2019
Q4
$8K Hold
70
﹤0.01% 2171
2019
Q3
$6K Sell
70
-13
-16% -$1.31K ﹤0.01% 2259
2019
Q2
$9K Buy
+83
New +$9.15K ﹤0.01% 2415

Other funds holding STRO